196 related articles for article (PubMed ID: 21614626)
1. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Ueno M; Uchiyama K; Ozawa S; Hayami S; Shigekawa Y; Tani M; Yamaue H
Ann Surg Oncol; 2011 Dec; 18(13):3624-31. PubMed ID: 21614626
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic chemolipiodolization for postoperative hepatoma patients.
Shimoda M; Bando T; Nagata T; Shirosaki I; Sakamoto T; Tsukada K
Hepatogastroenterology; 2001; 48(38):493-7. PubMed ID: 11379340
[TBL] [Abstract][Full Text] [Related]
3. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
4. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
5. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
8. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
Li T; Fan J; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY
Ann Surg Oncol; 2011 Jul; 18(7):1955-63. PubMed ID: 21240562
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
[TBL] [Abstract][Full Text] [Related]
11. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
13. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
[TBL] [Abstract][Full Text] [Related]
15. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
16. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
[TBL] [Abstract][Full Text] [Related]
18. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
[TBL] [Abstract][Full Text] [Related]
20. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]